Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 77.61

+3.5%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2616)	2/4/2010 9:48:04 AM
From: Jibacoa	Read Replies (1) of 3722

SQNM was up in premarket after some news.<g> It announced the launch of the SensiGene Fetal RHD Genotyping test. This is the company's first laboratory developed test powered by its SEQureDx technology. newscom.com In the US there are approximately 528,000 pregnancies in RhD negative women every year, and almost all of these women could benefit from an assessment of the RhD type of the fetus. The advantage of the test is that this could be done without an amniocentesis and or chorionic villus sampling, which involve some risk to the fetus. This is the first test based on SQNM's SEQureDx technology and is an important milestone for SQNM.<g> It is expected that this test will not run into the same problems that SQNM's test for Down's syndrome.<g> At any rate, the stock is up 8.21% at present. bigcharts.marketwatch.com But it didn't do as well after the market opened, with the DOW now down in triple digits again.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next